News

IPO Pipeline Swells: ~₹15,000 Crore of Issues Lined Up by End-July

Around five IPOs worth ~₹15,000 crore are lined up before end-July — led by Manipal Health, Milky Mist, Juniper Green, Caliber Mining and Lohia Corp — as India's primary market revives.

I

IPOLyst Team

IPOLyst Editorial

India's primary market is finding its feet again after a subdued spell, and the next few weeks look unusually crowded. Beyond SBI Funds Management's offer, set to open next week, roughly five more companies are reported to be readying public issues before July ends — together targeting around ₹15,000 crore.

India IPO pipeline July 2026 — five issues worth about ₹15,000 crore including Manipal Health, Milky Mist, Juniper Green, Caliber Mining and Lohia Corp, IPOLyst news infographic
India IPO pipeline July 2026 — five issues worth about ₹15,000 crore including Manipal Health, Milky Mist, Juniper Green, Caliber Mining and Lohia Corp, IPOLyst news infographic

The five names in the near-term queue

  • Manipal Health Enterprises — operator of the Manipal Hospitals network — a reported issue of about ₹9,500 crore.
  • Milky Mist Dairy Foods — a Tamil Nadu–based dairy products company — around ₹2,000 crore.
  • Juniper Green Energy — backed by AT Capital Group — about ₹1,800 crore, trimmed from an earlier ₹3,000 crore plan.
  • Caliber Mining & Logistics — among India's larger coal-mining services providers — roughly ₹500–600 crore.
  • Lohia Corp — a global maker of machinery for technical textiles — around ₹500 crore, structured as a pure offer-for-sale.

How the revival built up

The recovery has been gradual. June delivered seven listings worth about ₹2,718 crore, while July has already seen three — Knack Packaging, Kusumgar and Laser Power & Infra. Next week brings SBI Funds Management and Alpine Texworld. SBI's asset-management arm reportedly pared its offer to about ₹9,812.9 crore, down from an initially planned ₹11,692.9 crore, after selling a roughly 1.6% stake to marquee investors in a pre-IPO round.

Also watching the late-July window

Tonbo Imaging and pharma–biotech firm Symbiotec Pharmalab are said to be eyeing late July or early August, likely with smaller sizes than earlier envisaged. Zepto may also join the queue, though at a notably lower valuation than it once targeted.

The bigger picture

Momentum picked up after Jio Platforms and the National Stock Exchange filed draft papers last month. Cooling geopolitical tensions and softer crude prices are viewed as supportive for Indian equities, alongside renewed foreign-investor interest — and July and August are historically among the busiest stretches for new listings.

Issue sizes and timelines above are based on reports and remain subject to change.